Pfizer to acquire ResApp Health

BRISBANE, AUSTRALIA: ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, has entered into a binding scheme implementation deed with Pfizer Australia, under which it is proposed that Pfizer…